Suneva Medical Hires Chief Operating Officer

Preston Romm Suneva Medical

Suneva Medical, a privately-held aesthetics company, recently appointed Preston Romm to chief operating officer. Romm joins Suneva Medical with more than 30 years of experience and will be responsible for leading the company’s sales, marketing, and operations. Previously serving as president of Obagi Medical Products and senior vice president of Valeant Pharmaceuticals, Romm brings a rich background in the facial aesthetic industry and will be an instrumental executive on Suneva Medical’s leadership team. “Preston’s impressive track record and deep rooted experience in facial aesthetics is a welcomed addition,” says chairman and CEO Nicholas L. Teti, Jr. “As we enter another significant growth phase at Suneva, he will play a critical role in further elevating our position as an innovative aesthetics player that is committed to exceptional results and enduring patient satisfaction.”

Romm’s decades of senior leadership experience spans finance, marketing, sales, operations, and administration. Throughout his career, he has been responsible for overseeing financing growth strategies, negotiating and integrating mergers and acquisitions, supply chain management processes, ERP systems, internal controls ,and Sarbanes-Oxley compliance procedures. Romm holds an MBA from American University and a B.S. in Accounting from the University of Maryland. “Joining Suneva is a tremendous opportunity and I look forward to advancing its position within the general dermatology and aesthetic markets,” says Romm. “In a short time, the company has built a strong business foundation and it will be my top priority to strengthen opportunities within its operations, sales and marketing teams.”

Suggested Articles

Prioritizing your own health in the weeks and months before surgery is essential for proper recovery. Here are a few doctor-recommended tips to get you…

Customer acquisition costs a lot more than customer retention. In fact, according to the Harvard Business Review, depending on what industry you’re in, “…

This week the U.S. Food and Drug Administration (FDA) announced a voluntary global recall of Allergan’s Biocell textured breast implants.